Search the Newsreel

Rubric Capital Management LP Acquires 421,347 Shares of Kiniksa Pharmaceuticals International, plc $KNSA

Rubric Capital Management LP increased its stake in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) by 12.7%, acquiring an additional 421,347 shares and now owning 3.75 million shares worth $180.6 million. This makes Kiniksa Pharmaceuticals the 12th biggest holding for Rubric, representing 1.9% of its investment …

Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution

– ARCALYST¨ (rilonacept) Q2 2026 net product revenue of $243.6 million, representing ~55% year-over-year growth – – ARCALYST 2026 expected net product revenue increased to $980 - $995 million – – KPL-387 Phase 2 data demonstrated rapid and sustained reductions in pain and inflammation …

Kiniksa (Nasdaq: KNSA) boosts 2026 ARCALYST sales view after strong Q2

Kiniksa Pharmaceuticals International reported strong second-quarter 2026 results, driven by its flagship therapy ARCALYST, leading to an increased 2026 net product revenue guidance of $980–$995 million for the drug. The company highlighted 55% year-over-year growth for ARCALYST, reaching $243.6 million in Q2, and noted …

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Posts Quarterly Earnings Results, Hits Estimates

Kiniksa Pharmaceuticals stock rises 2% on raised guidance, revenue beat

Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals International, plc Revenue Breakdown – NASDAQ:KNSA

Zacks.com featured highlights include American Outdoor Brands, Cimpress, National Energy Services Reunited, CTO Realty Growth and Kiniksa Pharmaceuticals International

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Kiniksa Pharmaceuticals International, Plc LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 28, 2026 at 8:30 a.m. Eastern Time to report its second quarter …

Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it. The …

Kiniksa Pharmaceuticals International (KNSA) Expected to Announce Quarterly Earnings on Tuesday

Kiniksa Pharmaceuticals: Leader In Pericarditis Merits Hold Rating After Recent Gains

Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Upside Already Priced In?

Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?

Kiniksa Pharmaceuticals International Plc (NASDAQ:KNSA) Presents a Compelling GARP Opportunity

Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In View

Ddev Plastiks closes trading window for Q1FY27 results

Ddev Plastiks Industries' (NSE:DDEVPLSTIK) Profits May Not Reveal Underlying Issues

Earnings Release: Here's Why Analysts Cut Their Ddev Plastiks Industries Limited (NSE:DDEVPLSTIK) Price Target To ₹320

Ddev Plastiks FY26 net profit rises 9%, targets 13% revenue growth in FY27

DDEV Plastiks Names New RTA Compliance Officer

Ddev Plastiks Industries Schedules Q4FY26 Earnings Call for May 26, 2026

We Think Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) Profit Is Only A Baseline For What They Can Achieve

Kiniksa Pharmaceuticals International (KNSA) Is Up 29.2% After Raising 2026 Net Product Revenue Guidance

Ddev Plastiks Industries Commences Commercial Operations of New XLPE Manufacturing Unit in Rajasthan

Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today

Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates

Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Recent Share Price Pullback

One Analyst's Revenue Estimates For Ddev Plastiks Industries Limited (NSE:DDEVPLSTIK) Are Surging Higher

Ddev Plastiks Uploads Q3FY26 Earnings Call Recording Following Regulatory Requirements

Ddev Plastiks Industries: Promoter Group Completes Share Transfer with Full Regulatory Compliance

Ddev Plastiks Industries Schedules Q3FY26 Earnings Conference Call for February 10, 2026

Ddev Plastiks Industries Ltd. Share Price Live Today

DDEV Plastiks Industries Reports 17% Revenue Growth in Q2, Net Profit Rises 5.3%

Little Excitement Around Ddev Plastiks Industries Limited's (NSE:DDEVPLSTIK) Earnings

PT Pradiksi Gunatama Tbk (PGUN.JK) stock price, news, quote and history